RIVA, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 6.529
NA - Nord America 2.343
EU - Europa 1.170
SA - Sud America 354
AF - Africa 60
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.482
Nazione #
SG - Singapore 4.946
US - Stati Uniti d'America 2.249
CN - Cina 732
IT - Italia 578
HK - Hong Kong 478
BR - Brasile 238
GB - Regno Unito 185
VN - Vietnam 140
FR - Francia 139
DE - Germania 80
IN - India 63
CA - Canada 50
AR - Argentina 40
NL - Olanda 35
MX - Messico 28
ID - Indonesia 27
TR - Turchia 24
AU - Australia 23
ZA - Sudafrica 22
BD - Bangladesh 21
EC - Ecuador 21
FI - Finlandia 21
UA - Ucraina 20
PL - Polonia 17
CZ - Repubblica Ceca 16
RU - Federazione Russa 15
PY - Paraguay 14
ES - Italia 13
JP - Giappone 12
IQ - Iraq 11
MA - Marocco 11
CO - Colombia 10
MD - Moldavia 10
PH - Filippine 10
PK - Pakistan 10
SA - Arabia Saudita 10
VE - Venezuela 10
CL - Cile 8
PE - Perù 7
DZ - Algeria 5
EE - Estonia 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CH - Svizzera 4
MY - Malesia 4
SE - Svezia 4
TH - Thailandia 4
UY - Uruguay 4
AT - Austria 3
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KH - Cambogia 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
RO - Romania 2
SI - Slovenia 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
NR - Nauru 1
PR - Porto Rico 1
Totale 10.472
Città #
San Jose 845
Ashburn 543
Singapore 525
Hong Kong 476
Rome 369
Hefei 283
Boardman 194
Beijing 171
London 157
Lauterbourg 121
Shanghai 98
Dallas 81
Council Bluffs 70
Ho Chi Minh City 59
New York 48
Los Angeles 37
San Francisco 36
Santa Clara 31
Munich 30
São Paulo 29
Milan 25
Toronto 25
Pune 24
Hanoi 22
Seattle 20
Amsterdam 19
Washington 18
Warsaw 16
West Jordan 15
Brno 13
Brooklyn 12
Helsinki 11
Melbourne 10
Mexico City 10
Sydney 10
Tokyo 10
Turku 10
Boston 9
Hangzhou 9
Montreal 9
Quito 9
Brescia 8
Chicago 8
Da Nang 8
Nuremberg 8
Chennai 7
Johannesburg 7
Naples 7
Frankfurt am Main 6
Guayaquil 6
Haiphong 6
Hải Dương 6
New Delhi 6
Rio de Janeiro 6
Atlanta 5
Belo Horizonte 5
Buffalo 5
Campinas 5
Curitiba 5
Jakarta 5
Lima 5
Manchester 5
Orem 5
Turin 5
Asunción 4
Bari 4
Bologna 4
Cape Town 4
Charlotte 4
Denver 4
Ferrara 4
Krasnodar 4
Lahore 4
Medellín 4
Montevideo 4
Najaf 4
Redmond 4
Secaucus 4
Settimo Torinese 4
Sona 4
Stockholm 4
The Dalles 4
Verona 4
Ananindeua 3
Basel 3
Berlin 3
Biên Hòa 3
Bogotá 3
Canberra 3
Centurion 3
Cotia 3
Genoa 3
Guangzhou 3
Guarulhos 3
Haikou 3
Istanbul 3
Katueté 3
Kuala Lumpur 3
Miami 3
Paris 3
Totale 4.775
Nome #
Real-time polymerase chain reaction with melting analysis of positive blood culture specimens in bloodstream infections: diagnostic value and turnaround time 238
A case of hepatitis B virus infection in Eritrean Diciotti migrant: phylogenetic analysis and 'mirror effect' 237
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 237
Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 232
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 228
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 223
Alterazioni del sistema interferon in patologie umane: basi biologiche per un intervento terapeutico [The alteration of IFN system in human diseases: Biological basis for a therapy] 222
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 221
SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department 217
Comparison of the Allplex TM Respiratory Panel Assays and the Automated Fast Track Diagnostics Respiratory Pathogens 21 Assay for the Diagnosis of Pediatric Respiratory Viral Infections 214
). Diagnosi Delle Infezioni Virali 204
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 197
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 196
Aspetti virologici della patogenesi dell’infezione da HIV 189
Capitolo 26. Spirochete 176
Cine¬tica di replicazione dell'HIV su C8166: aspetti biologici ed applicativi. 172
Antibodies to IFN in chronic patients treated with rIFN alpha. 171
Influenza B virus infection complicated by life-threatening pericarditis: A unique case-report and literature review 157
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women 150
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 133
Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis [Il virus dell'immunodeficienza acquisita (HIV-1). Aspetti biologici e diagnosi virologica] 129
An acute febrile outbreak in a refugee community of an Italian asylum seeker center: lessons learned. Ciccozzi M., Riva E. share co-first authorship 123
MALDI-TOF MS Identification and Clustering Applied to Enterobacter Species in Nosocomial Setting 123
Genomic Epidemiology Unveil the Omicron Transmission Dynamics in Rome, Italy 121
Cronobacter sakazakii DNA detection in cerebrospinal fluid of a patient with amyotrophic lateral sclerosis mimic syndrome 119
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision 118
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? 114
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 113
Classificazione E Struttura Dei Virus Animali 113
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. 112
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 109
Diffuse maculopapular rash: A family cluster during the last Chikungunya virus epidemic in Italy 108
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 106
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy 105
Classificazione E Struttura Dei Virus 102
Azione antivirale dell'interferon e di altri inibitori naturali. Giornale Italiano di Chemioterapia 101
Alteration of thymidine kinase activity in cells treated with an antiviral agent. 100
Anti-interferon (IFN) antibodies in patients with relapsing remitting multipla sclerosis treated with recombinant IFN1a or IFN1b 99
Cellular factors leading to AZT resistance of HIV. 97
High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic 71
In Vitro Selection Of Human Immunodeficiency Virus Type 1 Resistant To 3'-Azido-3'-Deoxythymidine. 70
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology 64
IS HUMAN IMMUNODEFICIENCY VIRUS RNA LOAD COMPOSED OF NEUTRALIZED IMMUNE COMPLEXES? 64
“Classificazione e struttura dei virus” 63
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 62
Human Immunodeficiency Virus (HIV) DNA load and the level of immunosuppression in Treatment-Naïve HIV-1 Infected Patients 60
Quantitative hiv-1 proviral DNA detection: a multicentre analysis 59
Was Aldo Castellani the inventor of combined and polyvalent vaccines? 58
Influence of Hepatitis C virus (HCV) genotype, HCV RNA load and ALT level on reduction of HCV RNA after a single administration of interferon alpha 57
IMMUNOCOMPLESSI CIRCOLANTI (IC) IN PAZIENTI HCV POSITIVI 57
Diagnosi Delle Infezioni Virali 56
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 55
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 54
Spirochete (Cap. 26) 53
Plasma HIV viremia and viral load in lymph nodes 52
Diagnosi delle Infezioni Virali 52
THE NUMBER OF HIV DNA-INFECTED MONONUCLEAR CELLS IS REDUCED UNDER HAART PLUS RECOMBINANT IL-2 51
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples 49
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 48
Neutralizing and Nonneutralizing antibodies to IFN in hepatitis patients treated with different IFN alpha preparations. 48
Zidovudine induces the expression of cellular resistance affecting its antiviral activity. 48
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients 48
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 47
Patogenesi Dell'infezione Da HIV: Determinazione Quantitativa Del DNA Provirale Nel Monitoraggio Clinico Terapeutico 47
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 47
Fattori di non progressione nell'infezione da HIV. 47
The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mrnas for interferon-induced proteins. Intervirology 47
Role of the IL28B Rs12979860 C/T Polymorphism on the Incidence of Clinically-Active Cytomegalovirus Infection in Autologous Stem Cell Transplant Patients 47
Drug-induced cell mediated mechanism leading to resistance of HIV to AZT 47
IMPROVEMENT OF INTERLEUKIN 2 PRODUCTION, CLONOGENIC CAPABILITY AND RESTORATION OF STROMAL CELL FUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 46
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. 46
IMPACT OF THE IL28B RS12979860 CT POLYMORPHISM ON THE CYTOMEGALOVIRUS REACTIVATION IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS 46
LA COINFEZIONE HIV/HPV 46
“Classificazione e struttura dei virus” 45
Spirochete 45
Sinergismo fra AZT e ddI nell'infezione da HIV-1: aspetti biologici ed applica¬tivi. 45
STUDIO SULLE MUTAZIONI DI HIV-1 ASSOCIATE A FARMACORESISTENZA NEL PLASMA E NELLE CELLULE MONONUCLEATE DI SANGUE PERIFERICO 45
vitro selection of HIV-1 resistance to ddI is no as efficient as for the other antiretroviral drugs and yields virus which shows reduced cytophatic activity. 45
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy 44
Susceptibility to measles in migrant population: implication for policy makers. Ceccarelli G., Vita S., Riva E. share co-first authorship 44
Decay of HIV Type 1 DNA and development of drug-resistant mutants in patients with primary HIV Type 1 infection receiving highly active antiretroviral therapy. 43
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy 43
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 43
The SARS-CoV-2 Epidemic: How the Italian Public Is Being Informed 43
Evaluation of cellular associated HIV-1 DNA levels in HIV-1 infected patients receiving a long term of highly active antiretroviral therapy 43
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support 42
LYSOSOMAL ACID LIPASE ACTIVITY IS REDUCED IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED WITH SURROGATE INDICES OF PORTAL HYPERTENSION 42
MIGLIORAMENTO DELLA PERFORMANCE E GESTIONE DELLA ROUTINE MOLECOLARE NEL LABORATORIO DI VIROLOGIA DEL POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO (UCBM) ATTRAVERSO L’UTILIZZO DI UN SISTEMA COMPLETAMENTE AUTOMATICO. 42
Studio sulla farmacoresistenza cellulare all'AZT 42
Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy 41
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay 41
Il virus dell'immunodeficienza acquisita: aspetti biologici e diagnosi virologica. 41
Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication 40
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance 40
Rapid Detection of Methicillin-Resistant Staphylococcus aureus Directly from Blood for the Diagnosis of Bloodstream Infections: A Mini-Review 40
Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. 40
In Vitro Selection Of Hummunodeficiency Virus Type-1 Resistant To RO-318959 Pro¬teinase Inhibitor. 40
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy 39
The prolonged treatment with AZT may induce, in vitro and in vivo, a defect of thymidine kinase activity. 39
La reazione di polimerizzazione a catena. 39
Totale 9.074
Categoria #
all - tutte 66.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 1 1 1 1 12 6 2 177
2022/202381 3 1 1 2 9 1 4 6 3 8 39 4
2023/2024530 13 62 19 44 59 230 2 22 2 23 7 47
2024/20255.522 84 30 185 49 51 97 82 13 377 392 1.920 2.242
2025/20264.171 431 235 250 445 218 209 1.276 296 361 346 104 0
Totale 10.505